Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent illness and the leading cause of chronic liver disease globally, yet the condition receives little attention from the global public health community.
In 2020 and 2021 EILF is partnering with Wilton Park to hold a series of NAFLD dialogues. The series will address a broad range of issues with the aim of advancing the global NAFLD agenda.
The first two dialogues in the series convened over 30 leading clinicians, researchers and patient advocates from across Europe and North America for detailed discussions on what concrete actions can be taken to improve models of care for NAFLD patients
Read about dialogues and the key conclusions in the event report.